ADICON HOLDINGS (09860.HK): Appoints Ms. Feng Danlong as Independent Non-Executive Director

NewTimeSpace News: On 25 August 2026, Adicon Holdings Limited (stock code: 09860) announced the appointment of Ms. Feng Danlong as an independent non-executive director and a member of the remuneration committee, with effect from 25 August 2026, for a term of up to three years, with an annual director's fee of RMB 260,000.

Ms. Feng has over 33 years of senior management experience in human resources, corporate public affairs in the Asia-Pacific region and pharmaceutical industry policy engagement. She has been the founder of Shanghai Wenzhang Business Consulting Co., Ltd. since March 2023, and previously worked at Pfizer from 1990 to 2023, lastly as senior corporate advisor of Pfizer Investment Co., Ltd. She holds a bachelor's degree from Shandong University, an MBA from the School of Management of the State University of New York at Buffalo and a doctorate in management from Dalian University of Technology. Separately, Mr. Zhang Wei has resigned as a member of the remuneration committee with effect from the same day.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.